121 related articles for article (PubMed ID: 8246831)
1. Loss of the basement membrane matrix molecule, bamin, in diphenylamine-treated mice.
Rohrbach DH; Robinson LK; Murrah VA
Matrix; 1993 Sep; 13(5):341-50. PubMed ID: 8246831
[TBL] [Abstract][Full Text] [Related]
2. Comparison of human polycystic and medullary cystic kidney disease with diphenylamine-induced cystic disease.
Evan AP; Gardner KD
Lab Invest; 1976 Jul; 35(1):93-101. PubMed ID: 940325
[TBL] [Abstract][Full Text] [Related]
3. Tubular basement membrane change occurs pari passu with the development of cyst formation.
Carone FA; Hollenberg PF; Nakamura S; Punyarit P; Glogowski W; Flouret G
Kidney Int; 1989 Apr; 35(4):1034-40. PubMed ID: 2709683
[TBL] [Abstract][Full Text] [Related]
4. Specific changes in the basement membrane of the proximal tubules in the murine polycystic kidney detected by the novel anti-basement membrane monoclonal antibody D28.
Nagao S; Koyama Y; Takahashi H
Jikken Dobutsu; 1994 Oct; 43(4):511-9. PubMed ID: 7528684
[TBL] [Abstract][Full Text] [Related]
5. Tubular basement membrane changes during induction and regression of drug-induced polycystic kidney disease.
Carone FA; Butkowski RJ; Nakamura S; Polenakovic M; Kanwar YS
Kidney Int; 1994 Nov; 46(5):1368-74. PubMed ID: 7853795
[TBL] [Abstract][Full Text] [Related]
6. Altered mRNA expression of basement membrane components in a murine model of polycystic kidney disease.
Ebihara I; Killen PD; Laurie GW; Huang T; Yamada Y; Martin GR; Brown KS
Lab Invest; 1988 Mar; 58(3):262-9. PubMed ID: 3279260
[TBL] [Abstract][Full Text] [Related]
7. Basement membrane chondroitin sulfate proteoglycan alterations in a rat model of polycystic kidney disease.
Ehara T; Carone FA; McCarthy KJ; Couchman JR
Am J Pathol; 1994 Mar; 144(3):612-21. PubMed ID: 7510458
[TBL] [Abstract][Full Text] [Related]
8. Development of renal basement membrane glycoproteins in metanephric organ culture.
Avner ED; Jaffe R; Temple T; Ellis D; Chung AE
Lab Invest; 1983 Mar; 48(3):263-8. PubMed ID: 6827806
[TBL] [Abstract][Full Text] [Related]
9. Potential causes and pathogenesis in autosomal dominant polycystic kidney disease.
Milutinovic J; Agodoa LY
Nephron; 1983; 33(2):139-44. PubMed ID: 6835461
[TBL] [Abstract][Full Text] [Related]
10. Cell polarity in human renal cystic disease.
Carone FA; Nakamura S; Caputo M; Bacallao R; Nelson WJ; Kanwar YS
Lab Invest; 1994 May; 70(5):648-55. PubMed ID: 8196361
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a cell line from the EHS tumor: biosynthesis of basement membrane constituents and characterization of a hybrid proteoglycan containing heparan and chondroitin sulfate chains.
Danielson KG; Martinez-Hernandez A; Hassell JR; Iozzo RV
Matrix; 1992 Feb; 12(1):22-35. PubMed ID: 1560787
[TBL] [Abstract][Full Text] [Related]
12. Polycystic kidney disease: a predominance of giant nephrons.
Grantham JJ
Am J Physiol; 1983 Jan; 244(1):F3-10. PubMed ID: 6336912
[TBL] [Abstract][Full Text] [Related]
13. Diabetic microangiopathy. I. Current status of the chemistry and metabolism of the glomerular basement membrane.
Reddi AS
Metabolism; 1978 Jan; 27(1):107-24. PubMed ID: 339033
[TBL] [Abstract][Full Text] [Related]
14. A hypomorphic mutation in the mouse laminin alpha5 gene causes polycystic kidney disease.
Shannon MB; Patton BL; Harvey SJ; Miner JH
J Am Soc Nephrol; 2006 Jul; 17(7):1913-22. PubMed ID: 16790509
[TBL] [Abstract][Full Text] [Related]
15. Chemically induced polycystic kidney disease.
Crocker JF; Blecher SR; Safe SH
Prog Clin Biol Res; 1983; 140():281-96. PubMed ID: 6369340
[No Abstract] [Full Text] [Related]
16. A membranous nephropathy associated with adult polycystic kidney disease.
Shikata K; Makino H; Ota Z
Clin Nephrol; 1991 Nov; 36(5):223-7. PubMed ID: 1752071
[TBL] [Abstract][Full Text] [Related]
17. [Experimental cystic renal degeneration].
Chodorowski Z
Pol Tyg Lek; 1978 Feb; 33(8):323-5. PubMed ID: 634858
[No Abstract] [Full Text] [Related]
18. The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.
Lager DJ; Qian Q; Bengal RJ; Ishibashi M; Torres VE
Kidney Int; 2001 Jan; 59(1):126-36. PubMed ID: 11135065
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the basement membrane (heparan sulfate) proteoglycan in diabetic mice.
Rohrbach DH; Hassell JR; Kleinman HK; Martin GR
Diabetes; 1982 Feb; 31(2):185-8. PubMed ID: 7152128
[TBL] [Abstract][Full Text] [Related]
20. Formation of basement membranes in the embryonic kidney: an immunohistological study.
Ekblom P
J Cell Biol; 1981 Oct; 91(1):1-10. PubMed ID: 6795211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
